Genomics

Dataset Information

0

Targeting the scaffolding role of LSD1(KDM1A) poises acute myeloid leukemia cells for Retinoic Acid induced differentiation [ChIP-seq]


ABSTRACT: The histone demethylase LSD1 is deregulated in several tumors, including leukemias, providing the rationale for the clinical use of LSD1 inhibitors . In acute promyelocytic leukemia (APL), pharmacological doses of retinoic acid (RA) induce differentiation of APL cells through degradation of the PML-RAR oncogene. APL cells are resistant to LSD1 inhibition or knock-out, but LSD1 inhibition sensitizes them to physiological doses of RA without altering the stability of PML-RAR, and extends survival of leukemic mice upon RA treatment. Non-enzymatic activities of LSD1 are essential to block differentiation of leukemic cells, while the combination of LSD1 inhibitors (or LSD1 knock-out) with low doses of RA releases a differentiation-associated gene expression program, not strictly dependent on changes in histone H3K4 methylation (known substrate of LSD1). An integrated proteomic/epigenomic/mutational analysis showed that LSD1 inhibitors alter the recruitment of LSD1-containing complexes to chromatin through inhibition of the interaction between LSD1 and GFI1, a relevant transcription factor in hematopoiesis.

OTHER RELATED OMICS DATASETS IN: PXD012954

ORGANISM(S): Homo sapiens

PROVIDER: GSE128528 | GEO | 2020/04/20

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2020-05-26 | PXD012954 | Pride
2020-04-20 | GSE128529 | GEO
2008-11-17 | E-GEOD-11379 | biostudies-arrayexpress
2008-11-18 | GSE11379 | GEO
2009-12-17 | E-GEOD-18886 | biostudies-arrayexpress
2009-12-17 | GSE18886 | GEO
2004-12-31 | E-MEXP-149 | biostudies-arrayexpress
2014-01-11 | E-GEOD-51723 | biostudies-arrayexpress
2016-12-31 | GSE72528 | GEO
2010-07-29 | E-GEOD-23291 | biostudies-arrayexpress